By RFD Radio/WFMB
WASHINGTON – U.S. Sen. Tammy Duckworth (D-Ill.), along with colleague Dick Durbin, is seeing red after another pharmaceutical company dramatically increased the price of a life saving medication.
The two Senators from Illinois teamed up with 29 other Senators to demand answers from Kaléo Pharmaceuticals for massive price hikes for an easy to use injector device that contains opioid overdose drug Naloxone and the injector device Evzio The price has surged from $690 in 2014 to $4,500 now. Duckworth says in many price gouging cases, the companies are pharmaceutical in name only.
“Here’s the thing that bugs me the most about this the fact that these companies that do this, whether they do it with the EpiPen with Naloxone, there are also doing it with diabetes, with insulin,” Duckworth said.
You may not have to worry about opioid addiction, but Duckworth said you’re impacted by the price surges regardless.
“It does cost the taxpayers money because the insurance we all pay, that cost gets spread around to all the rest of us,” Duckworth said. “It’s not acceptable.”
The 31 Senators say the price hike threatens to price-out families and communities that depend on Naloxone to save lives.